Salsalate
- Generic Name
- Salsalate
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C14H10O5
- CAS Number
- 552-94-3
- Unique Ingredient Identifier
- V9MO595C9I
- Background
Salsalate is a nonsteroidal anti-inflammatory agent for oral administration. Salsalate's mode of action as an anti-inflammatory and antirheumatic agent may be due to inhibition of synthesis and release of prostaglandins. The usefulness of salicylic acid, the active in vivo product of salsalate, in the treatment of arthritic disorders has been established. In...
- Indication
For relief of the signs and symptoms of rheumatoid arthritis, osteoarthritis and related rheumatic disorders.
- Associated Conditions
- -
- Associated Therapies
- -
Salsalate, Venetoclax, and Decitabine or Azacitidine for the Treatment of Acute Myeloid Leukemia or Advanced Myelodysplasia/Myeloproliferative Disease
- Conditions
- Interventions
- First Posted Date
- 2019-10-31
- Last Posted Date
- 2023-05-24
- Lead Sponsor
- Rutgers, The State University of New Jersey
- Target Recruit Count
- 5
- Registration Number
- NCT04146038
- Locations
- 🇺🇸
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States
Oral Peri-operative TIming of Metformin (or) Salsalate to Improve Non-cardiac Surgery Glucose Control
- Conditions
- Interventions
- First Posted Date
- 2019-01-25
- Last Posted Date
- 2023-01-13
- Lead Sponsor
- McMaster University
- Registration Number
- NCT03816488
Salsalate in Patients Mild to Moderate Alzheimer's Disease
- First Posted Date
- 2017-09-11
- Last Posted Date
- 2021-04-01
- Lead Sponsor
- Adam Boxer
- Target Recruit Count
- 40
- Registration Number
- NCT03277573
- Locations
- 🇺🇸
University of California, San Francisco, San Francisco, California, United States
🇺🇸University of California, San Diego, San Diego, California, United States
Treating Inflammation in Polycystic Ovary Syndrome to Ameliorate Ovarian Dysfunction
- First Posted Date
- 2017-07-25
- Last Posted Date
- 2024-06-25
- Lead Sponsor
- University of Illinois at Chicago
- Target Recruit Count
- 60
- Registration Number
- NCT03229408
- Locations
- 🇺🇸
Frank González, Chicago, Illinois, United States
The Comparison of Effect Between Salsalate and Placebo in Osteoarthritis With Nonalcoholic Fatty Liver Disease
- Conditions
- Interventions
- First Posted Date
- 2017-07-19
- Last Posted Date
- 2019-08-22
- Lead Sponsor
- Korea University Guro Hospital
- Target Recruit Count
- 34
- Registration Number
- NCT03222206
- Locations
- 🇰🇷
Korea University Guro Hospital, Seoul, Korea, Republic of
Targeting Inflammation With Salsalate in Type 1 Diabetes Neuropathy
- Conditions
- Interventions
- First Posted Date
- 2016-10-18
- Last Posted Date
- 2023-07-10
- Lead Sponsor
- University of Michigan
- Target Recruit Count
- 61
- Registration Number
- NCT02936843
- Locations
- 🇺🇸
University of Michigan Health System, Ann Arbor, Michigan, United States
🇺🇸Veterans Administration Ann Arbor Health Center, Ann Arbor, Michigan, United States
A 6 Month, Open-Label, Pilot Futility Clinical Trial of Oral Salsalate for Progressive Supranuclear Palsy
- First Posted Date
- 2015-04-21
- Last Posted Date
- 2021-04-01
- Lead Sponsor
- Adam Boxer
- Target Recruit Count
- 10
- Registration Number
- NCT02422485
- Locations
- 🇺🇸
OHSU Parkinson Center & Movement Disorder Program, Portland, Oregon, United States
🇺🇸University of California, San Francisco, San Francisco, California, United States
Free Fatty Acids-Induced Hypertension in Obese Subjects (Aim #2)
- Conditions
- Interventions
- First Posted Date
- 2015-04-02
- Last Posted Date
- 2019-01-08
- Lead Sponsor
- Emory University
- Target Recruit Count
- 36
- Registration Number
- NCT02406586
- Locations
- 🇺🇸
Grady Memorial Hospital, Atlanta, Georgia, United States
Beneficial Effect of Salicylates: Insulin Action, Secretion or Clearance?
- Conditions
- Interventions
- First Posted Date
- 2013-12-11
- Last Posted Date
- 2016-05-05
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 41
- Registration Number
- NCT02007577
- Locations
- 🇺🇸
Stanford University School of Medicine, Stanford, California, United States
Inflammation Inhibition in Prediabetic Humans
- First Posted Date
- 2013-11-06
- Last Posted Date
- 2023-09-11
- Lead Sponsor
- Gary L. Pierce
- Target Recruit Count
- 21
- Registration Number
- NCT01977417
- Locations
- 🇺🇸
University of Iowa, Iowa City, Iowa, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.